| Medicare Palmetto | Billing and Coding: MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis (60205) | 2026-09-15 |
| Medicare Wellpoint NGS | Billing and Coding: Facet Joint Interventions for Pain Management (57826) | 2026-09-15 |
| Aetna | Positron Emission Tomography (PET) | 2026-09-14 |
| BCBS Highmark Penn Medicare Advantage | Entranacogene dezaparvovec (Hemgenix) | 2026-09-14 |
| BCBS Highmark NY and West NY | Gender Affirmation Treatment | 2026-09-14 |
| BCBS Highmark Delaware | Gender Affirmation Treatment | 2026-09-14 |
| BCBS Highmark West Virginia | Gender Affirmation Treatment | 2026-09-14 |
| BCBS Highmark West Virginia | ADAMTS13, recombinant-krhn (Adzynma) | 2026-09-14 |
| BCBS Highmark Delaware | ADAMTS13, recombinant-krhn (Adzynma) | 2026-09-14 |
| BCBS Highmark NY and West NY | ADAMTS13, recombinant-krhn (Adzynma) | 2026-09-14 |